ABEONA THERAPEUTICS INC. (ABEO) Return on equity 2016–2025
ABEONA THERAPEUTICS INC. (ABEO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
44.7%FY2025 · since FY2016: -22.1% → 44.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 44.7% | — |
| FY2023 | -365.5% | -217.2 pp |
| FY2022 | -148.3% | +52.1 pp |
| FY2021 | -200.5% | -118.3 pp |
| FY2020 | -82.1% | — |
| FY2018 | -42.3% | -26.2 pp |
| FY2017 | -16.1% | +6.0 pp |
| FY2016 | -22.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ABEO financial trends
ABEO RevenueABEO Net incomeABEO Net marginABEO Gross profitABEO Gross marginABEO Operating incomeABEO Operating marginABEO Operating cash flowABEO Free cash flowABEO Capital expendituresABEO Stock buybacksABEO Dividends paidABEO Total assetsABEO Total liabilitiesABEO Shareholders’ equityABEO overview →